JPS61143376A - １，４‐ジヒドロピリジン類 - Google Patents

１，４‐ジヒドロピリジン類

Info

Publication number
JPS61143376A
JPS61143376A JP60275229A JP27522985A JPS61143376A JP S61143376 A JPS61143376 A JP S61143376A JP 60275229 A JP60275229 A JP 60275229A JP 27522985 A JP27522985 A JP 27522985A JP S61143376 A JPS61143376 A JP S61143376A
Authority
JP
Japan
Prior art keywords
formula
lower alkyl
hydrogen
compound
formulas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60275229A
Other languages
English (en)
Japanese (ja)
Inventor
リチヤード・シー・アレン
リチヤード・シー・エフランド
ジヨゼフ・テイー・クライン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Roussel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharmaceuticals Inc filed Critical Hoechst Roussel Pharmaceuticals Inc
Publication of JPS61143376A publication Critical patent/JPS61143376A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP60275229A 1984-12-10 1985-12-09 １，４‐ジヒドロピリジン類 Pending JPS61143376A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US680036 1984-12-10
US06/680,036 US4578394A (en) 1984-12-10 1984-12-10 Cholinergic function increasing 3-[N-(pyridyl) carbamoyl]-1,4-dihydropyridines

Publications (1)

Publication Number Publication Date
JPS61143376A true JPS61143376A (ja) 1986-07-01

Family

ID=24729393

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60275229A Pending JPS61143376A (ja) 1984-12-10 1985-12-09 １，４‐ジヒドロピリジン類

Country Status (7)

Country Link
US (1) US4578394A (enExample)
EP (1) EP0187251A3 (enExample)
JP (1) JPS61143376A (enExample)
DK (1) DK568285A (enExample)
ES (1) ES8706670A1 (enExample)
GR (1) GR852956B (enExample)
PT (1) PT81629B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007169259A (ja) * 2005-07-14 2007-07-05 Sumitomo Chemical Co Ltd カルボキサミド化合物及びその植物病害防除用途

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816416A (en) * 1986-08-27 1989-03-28 Paul Averback Microspheric bodies for use in screening therapies for Azheimer's disease and related conditions
US5231170A (en) * 1986-08-27 1993-07-27 Paul Averback Antibodies to dense microspheres
US5202440A (en) * 1987-10-05 1993-04-13 Pfizer Inc. Certain 9-amino-2-(or 4)-oxa 1,2,3,4-tetrahydro- or 1,2,3,4,5,6,7,8-octahydro-acridines
WO1989002739A1 (en) * 1987-10-05 1989-04-06 Pfizer Inc. 4-aminopyridine derivatives
US5212188A (en) * 1992-03-02 1993-05-18 R. J. Reynolds Tabacco Company Method for treatment of neurodegenerative diseases
US5242934A (en) * 1992-03-02 1993-09-07 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5242935A (en) * 1992-03-06 1993-09-07 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5288872A (en) * 1992-03-13 1994-02-22 Wake Forest University Compounds for treatment of neurodegenerative diseases
US5227385A (en) * 1992-03-13 1993-07-13 Wake Forest University Method for treatment of neurodegenerative diseases
US5276043A (en) * 1992-04-10 1994-01-04 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5187169A (en) * 1992-04-10 1993-02-16 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5214060A (en) * 1992-04-10 1993-05-25 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5232932A (en) * 1992-05-21 1993-08-03 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5232933A (en) * 1992-05-21 1993-08-03 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5248690A (en) * 1992-07-07 1993-09-28 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5242916A (en) * 1992-07-07 1993-09-07 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5824692A (en) * 1995-01-06 1998-10-20 Lippiello; Patrick Michael Pharmaceutical compositions for prevention and treatment of central nervous system disorders
US5583140A (en) * 1995-05-17 1996-12-10 Bencherif; Merouane Pharmaceutical compositions for the treatment of central nervous system disorders
PL190755B1 (pl) * 1999-01-07 2006-01-31 Pharmena Sp Z Oo Preparat do leczenia i profilaktyki chorób skóry
JP5034293B2 (ja) * 2005-07-14 2012-09-26 住友化学株式会社 カルボキサミド化合物及びこれを含有する植物病害防除剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0083378A1 (en) * 1981-12-22 1983-07-13 Chugai Seiyaku Kabushiki Kaisha Tetrahydronicotinamide derivatives, a process for producing the same and a pharmaceutical composition comprising the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007169259A (ja) * 2005-07-14 2007-07-05 Sumitomo Chemical Co Ltd カルボキサミド化合物及びその植物病害防除用途

Also Published As

Publication number Publication date
DK568285D0 (da) 1985-12-09
EP0187251A3 (en) 1987-04-29
US4578394A (en) 1986-03-25
EP0187251A2 (en) 1986-07-16
ES549713A0 (es) 1987-06-16
PT81629B (en) 1987-10-13
ES8706670A1 (es) 1987-06-16
DK568285A (da) 1986-06-11
GR852956B (enExample) 1986-04-01
PT81629A (en) 1986-01-01

Similar Documents

Publication Publication Date Title
JPS61143376A (ja) １，４‐ジヒドロピリジン類
AU2005268030B2 (en) Aromatic compounds
CA2417475C (en) Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacterien
JPS6360968A (ja) キノリン誘導体
JPS63238063A (ja) 置換９−アミノ−テトラヒドロアクリジンおよび関連化合物
EP0892796B1 (en) Isatin derivatives as acetylcholinesterase inhibitors and analgesics
JPS5995269A (ja) 抗てんかん性医薬品
JPH04507421A (ja) ５―（１―アミノシクロヘキシル）―２（１ｈ）―ピリジノン及び関連化合物
JPH06506671A (ja) 新規サリドマイド誘導体、その製造方法並びにこれを薬剤として使用する方法
KR0164437B1 (ko) 1-(피리디닐아미노)-2-피롤리디논, 이의 제조방법 및 이를 포함하는 약제학적 조성물
JPS62145049A (ja) アミノスチリル化合物及びそれを有効成分とするロイコトリエンきつ抗剤
JPH07504666A (ja) プリン類似化合物の抗ウイルス性ホスホン酸誘導体
WO1997026242A1 (en) 3-(bis-substituted-phenylmethylene)oxindole derivatives
JP3057829B2 (ja) ３−（１，２−ベンズイソキサゾール−３−イル）−４−ピリジンアミンおよび誘導体
JPS6287574A (ja) 新規なｎ置換３，４−ジヒドロピリミジン−２−オン誘導体、その製造法及び循環器系疾患治療剤
JP2567593B2 (ja) イミダゾリジントリオン誘導体及び該化合物を有効成分として含有するアレルギ−性疾患治療剤
JPS62281860A (ja) アルキレンアミノアルキレン　ヘテロ原子基を有するジヒドロ−３，５−ジカルボキシレ−ト
JPS63154663A (ja) ３，５−ジ−タ−シヤリ−ブチル−４−ヒドロキシケイ皮酸アミド誘導体
JP3009716B2 (ja) 新規なカンプトテシン誘導体
JPS61293981A (ja) １２ｂ−置換１−ヒドロキシメチル−オクタヒドロインドロ〔２，３−ａ〕キノリジン誘導体，それらの製造法及びそれらを含む医薬組成物
WO2000068231A1 (en) Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof
JPS6147452A (ja) エチレンジアミン誘導体及びその製造方法
JPH0466575A (ja) ２―ニトロイミダゾール誘導体及びそれを含有する抗原虫剤
JP2638189B2 (ja) カルボン酸イミド又はその酸付加塩及び抗不整脈剤
JP2025531133A (ja) ユビキチン特異的プロテアーゼ阻害剤としてのカルボニル縮合複素環誘導体